Exploring the positive allosteric modulation of human α7 nicotinic receptors from a single-channel perspective

Natalia D. Andersen, Beatriz E. Nielsen, Jeremías Corradi, María F. Tolosa, Dominik Feuerbach, Hugo R. Arias, Cecilia Bouzat

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Enhancement of α7 nicotinic receptor (nAChR) function by positive allosteric modulators (PAMs) is a promising therapeutic strategy to improve cognitive deficits. PAMs have been classified only on the basis of their macroscopic effects as type I, which only enhance agonist-induced currents, and type II, which also decrease desensitization and reactivate desensitized nAChRs. To decipher the molecular basis underlying these distinct activities, we explored the effects on single-α7 channel currents of representative members of each type and of less characterized compounds. Our results reveal that all PAMs enhance open-channel lifetime and produce episodes of successive openings, thus indicating that both types affect α7 kinetics. Different PAM types show different sensitivity to temperature, suggesting different mechanisms of potentiation. By using a mutant α7 receptor that is insensitive to the prototype type II PAM (PNU-120596), we show that some though not all type I PAMs share the structural determinants of potentiation. Overall, our study provides novel information on α7 potentiation, which is key to the ongoing development of therapeutic compounds.

Original languageEnglish
Pages (from-to)189-200
Number of pages12
JournalNeuropharmacology
Volume107
DOIs
StatePublished - 1 Aug 2016
Externally publishedYes

Fingerprint

Nicotinic Receptors
Temperature
Therapeutics
1-(5-chloro-2,4-dimethoxyphenyl)-3-(5-methylisoxazol-3-yl)urea

Keywords

  • Cys-loop receptors
  • Nicotinic receptors
  • Patch-clamp
  • Positive allosteric modulators
  • Single-channel recordings

Cite this

Andersen, Natalia D. ; Nielsen, Beatriz E. ; Corradi, Jeremías ; Tolosa, María F. ; Feuerbach, Dominik ; Arias, Hugo R. ; Bouzat, Cecilia. / Exploring the positive allosteric modulation of human α7 nicotinic receptors from a single-channel perspective. In: Neuropharmacology. 2016 ; Vol. 107. pp. 189-200.
@article{8fa441f4295e4e04b569545a35615ba7,
title = "Exploring the positive allosteric modulation of human α7 nicotinic receptors from a single-channel perspective",
abstract = "Enhancement of α7 nicotinic receptor (nAChR) function by positive allosteric modulators (PAMs) is a promising therapeutic strategy to improve cognitive deficits. PAMs have been classified only on the basis of their macroscopic effects as type I, which only enhance agonist-induced currents, and type II, which also decrease desensitization and reactivate desensitized nAChRs. To decipher the molecular basis underlying these distinct activities, we explored the effects on single-α7 channel currents of representative members of each type and of less characterized compounds. Our results reveal that all PAMs enhance open-channel lifetime and produce episodes of successive openings, thus indicating that both types affect α7 kinetics. Different PAM types show different sensitivity to temperature, suggesting different mechanisms of potentiation. By using a mutant α7 receptor that is insensitive to the prototype type II PAM (PNU-120596), we show that some though not all type I PAMs share the structural determinants of potentiation. Overall, our study provides novel information on α7 potentiation, which is key to the ongoing development of therapeutic compounds.",
keywords = "Cys-loop receptors, Nicotinic receptors, Patch-clamp, Positive allosteric modulators, Single-channel recordings",
author = "Andersen, {Natalia D.} and Nielsen, {Beatriz E.} and Jerem{\'i}as Corradi and Tolosa, {Mar{\'i}a F.} and Dominik Feuerbach and Arias, {Hugo R.} and Cecilia Bouzat",
year = "2016",
month = "8",
day = "1",
doi = "10.1016/j.neuropharm.2016.02.032",
language = "English",
volume = "107",
pages = "189--200",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Ltd",

}

Exploring the positive allosteric modulation of human α7 nicotinic receptors from a single-channel perspective. / Andersen, Natalia D.; Nielsen, Beatriz E.; Corradi, Jeremías; Tolosa, María F.; Feuerbach, Dominik; Arias, Hugo R.; Bouzat, Cecilia.

In: Neuropharmacology, Vol. 107, 01.08.2016, p. 189-200.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Exploring the positive allosteric modulation of human α7 nicotinic receptors from a single-channel perspective

AU - Andersen, Natalia D.

AU - Nielsen, Beatriz E.

AU - Corradi, Jeremías

AU - Tolosa, María F.

AU - Feuerbach, Dominik

AU - Arias, Hugo R.

AU - Bouzat, Cecilia

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Enhancement of α7 nicotinic receptor (nAChR) function by positive allosteric modulators (PAMs) is a promising therapeutic strategy to improve cognitive deficits. PAMs have been classified only on the basis of their macroscopic effects as type I, which only enhance agonist-induced currents, and type II, which also decrease desensitization and reactivate desensitized nAChRs. To decipher the molecular basis underlying these distinct activities, we explored the effects on single-α7 channel currents of representative members of each type and of less characterized compounds. Our results reveal that all PAMs enhance open-channel lifetime and produce episodes of successive openings, thus indicating that both types affect α7 kinetics. Different PAM types show different sensitivity to temperature, suggesting different mechanisms of potentiation. By using a mutant α7 receptor that is insensitive to the prototype type II PAM (PNU-120596), we show that some though not all type I PAMs share the structural determinants of potentiation. Overall, our study provides novel information on α7 potentiation, which is key to the ongoing development of therapeutic compounds.

AB - Enhancement of α7 nicotinic receptor (nAChR) function by positive allosteric modulators (PAMs) is a promising therapeutic strategy to improve cognitive deficits. PAMs have been classified only on the basis of their macroscopic effects as type I, which only enhance agonist-induced currents, and type II, which also decrease desensitization and reactivate desensitized nAChRs. To decipher the molecular basis underlying these distinct activities, we explored the effects on single-α7 channel currents of representative members of each type and of less characterized compounds. Our results reveal that all PAMs enhance open-channel lifetime and produce episodes of successive openings, thus indicating that both types affect α7 kinetics. Different PAM types show different sensitivity to temperature, suggesting different mechanisms of potentiation. By using a mutant α7 receptor that is insensitive to the prototype type II PAM (PNU-120596), we show that some though not all type I PAMs share the structural determinants of potentiation. Overall, our study provides novel information on α7 potentiation, which is key to the ongoing development of therapeutic compounds.

KW - Cys-loop receptors

KW - Nicotinic receptors

KW - Patch-clamp

KW - Positive allosteric modulators

KW - Single-channel recordings

UR - http://www.scopus.com/inward/record.url?scp=84962209410&partnerID=8YFLogxK

U2 - 10.1016/j.neuropharm.2016.02.032

DO - 10.1016/j.neuropharm.2016.02.032

M3 - Article

C2 - 26926428

AN - SCOPUS:84962209410

VL - 107

SP - 189

EP - 200

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

ER -